Company Overview - Akari Therapeutics is publicly listed on NASDAQ under the ticker AKTX [2] - The company is focusing on innovating antibody drug conjugates (ADCs) [3] Strategic Focus - Akari Therapeutics has redefined its vision to concentrate on oncology [3] - The company aims to develop immuno-oncology therapies to help patients achieve cancer-free status [4]